EUVIMEDEUVIMED entdecken
Open Access

Targeting the DNHD1‑HDAC6 axis inactivates prostate cancer cell aggressiveness in vitro, suggesting potential therapeutic vulnerability

An Ni Lee, Chia Chang Wu, Su Wei Hu, Chih Heng Chen, Yi Te Chiang, Wei Tang Kao, Kai Yi Tzou, Chia Hung Liu, Shao Wei Dong, Yu Ting Wang, Yueh Lin Lee, Siou Bi Li und 5 weitere

Oncology Reports · 2026

DOI: 10.3892/or.2026.9204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von An Ni Lee und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan 23561, R.O.C. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Prostatic Neoplasms. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 6Prostatic NeoplasmsMaleHumansGene Expression Regulation, NeoplasticCell ProliferationCell Line, TumorCell MovementPrognosisIndolesHydroxamic AcidsBiomarkers, TumorSignal TransductionDisease ProgressionAnimals

Stichwörter der Autor:innen

bioinformaticdynein heavy chain domain 1histone deacetylase 6prognosisprostate cancer

Substanzen

Histone Deacetylase 6HDAC6 protein, humantubastatin AIndolesHydroxamic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan 23561, R.O.C.
  • Department of Tropical Medicine, School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan 300093, R.O.C.
  • Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan 300093, R.O.C.

Zitieren

APA

Lee, A. N., Wu, C. C., Hu, S. W., Chen, C. H., Chiang, Y. T., Kao, W. T., Tzou, K. Y., Liu, C. H., Dong, S. W., Wang, Y. T., Lee, Y. L., Li, S. B., Wu, C. A., Liao, C. C., Chan, M. H., Chiu, P. H., & Li, C. H. (2026). Targeting the DNHD1‑HDAC6 axis inactivates prostate cancer cell aggressiveness in vitro, suggesting potential therapeutic vulnerability. Oncology Reports. https://doi.org/10.3892/or.2026.9204

Vancouver

Lee AN, Wu CC, Hu SW, Chen CH, Chiang YT, Kao WT, et al. Targeting the DNHD1‑HDAC6 axis inactivates prostate cancer cell aggressiveness in vitro, suggesting potential therapeutic vulnerability. Oncology Reports. 2026. doi:10.3892/or.2026.9204

BibTeX
@article{Lee2026,
  author = {Lee, An Ni and Wu, Chia Chang and Hu, Su Wei and Chen, Chih Heng and Chiang, Yi Te and Kao, Wei Tang and Tzou, Kai Yi and Liu, Chia Hung and Dong, Shao Wei and Wang, Yu Ting and Lee, Yueh Lin and Li, Siou Bi and Wu, Che An and Liao, Chiao Chun and Chan, Ming Hsien and Chiu, Po Han and Li, Chien Hsiu},
  title = {Targeting the DNHD1‑HDAC6 axis inactivates prostate cancer cell aggressiveness in vitro, suggesting potential therapeutic vulnerability},
  journal = {Oncology Reports},
  year = {2026},
  doi = {10.3892/or.2026.9204}
}
Kostenlos starten →